op 2507 has been researched along with ozagrel in 5 studies
| Studies (op 2507) | Trials (op 2507) | Recent Studies (post-2010) (op 2507) | Studies (ozagrel) | Trials (ozagrel) | Recent Studies (post-2010) (ozagrel) |
|---|---|---|---|---|---|
| 33 | 0 | 1 | 529 | 31 | 37 |
| Protein | Taxonomy | op 2507 (IC50) | ozagrel (IC50) |
|---|---|---|---|
| cystic fibrosis transmembrane conductance regulator | Homo sapiens (human) | 3.43 | |
| Thromboxane-A synthase | Homo sapiens (human) | 0.0864 | |
| Thromboxane-A synthase | Rattus norvegicus (Norway rat) | 0.2 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aoyama, T; Fukuse, S; Nagahara, K; Noi, O | 1 |
| Iwata, M | 1 |
| Iida, T; Kawarada, Y; Yokoi, H | 1 |
| Hao, Y; Honda, Y; Koike, Y; Mineshita, S; Miura, A; Wang, LM | 1 |
| Arima, T; Hirano, T; Kawano, R; Motoyama, K; Nakafusa, Y; Sugitani, A; Tanaka, M | 1 |
5 other study(ies) available for op 2507 and ozagrel
| Article | Year |
|---|---|
Effects of prostaglandins on perilymphatic oxygenation. Enhancement of cochlear autoregulation by prostacyclin.
Topics: Alprostadil; Animals; Blood Flow Velocity; Blood Pressure; Cats; Cochlea; Epoprostenol; Homeostasis; Labyrinthine Fluids; Methacrylates; Microcirculation; Oxygen Consumption; Perilymph; Regional Blood Flow; Ultrasonography | 1988 |
Pathophysiology of dogs after 84% hepatectomy with emphasis on prostaglandin metabolites and the effect of a thromboxane A2 synthesis inhibitor and a prostaglandin I2 analog.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Cause of Death; Dogs; Epoprostenol; Female; Hepatectomy; Histamine Antagonists; Hyaluronic Acid; Liver; Liver Function Tests; Male; Methacrylates; Prostaglandins; Radioimmunoassay; Survival Rate; Thromboxane B2; Thromboxane-A Synthase; Time Factors | 1994 |
The effects of a thromboxane A2 synthesis inhibitor and a prostaglandin I2 analogue on experimental acute necrotizing pancreatitis in rats.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Disease Models, Animal; Epoprostenol; Injections, Subcutaneous; Kidney; Lung; Male; Methacrylates; Pancreas; Pancreatitis, Acute Necrotizing; Phospholipases A; Phospholipases A2; Rats; Rats, Wistar; Survival Rate; Taurocholic Acid; Thromboxane A2; Thromboxane B2; Thromboxane-A Synthase; Time Factors | 1998 |
The effect of the prostaglandin I2 analogue OP-2507 on adrenaline-induced pulmonary edema in rabbits and analysis of hemodynamic changes.
Topics: Animals; Cyclooxygenase Inhibitors; Epinephrine; Epoprostenol; Flurbiprofen; Methacrylates; Models, Animal; Pulmonary Edema; Rabbits; Thromboxane-A Synthase | 2000 |
The combined use of prostaglandin I2 analogue (OP-2507) and thromboxane A2 synthetase inhibitor (OKY-046) strongly inhibits atherosclerosis of aortic allografts in rats.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Aorta; Arteriosclerosis; Cell Nucleus; Drug Therapy, Combination; Enzyme Inhibitors; Epoprostenol; Kinetics; Male; Methacrylates; Rats; Rats, Inbred Lew; Rats, Wistar; Superoxides; Thromboxane A2; Thromboxane-A Synthase; Transplantation, Homologous | 2001 |